ArticleFrontiers in immunology2024

Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas.

Jiapeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.